Datasets:

Modalities:
Text
Formats:
json
Languages:
English
ArXiv:
Libraries:
Datasets
pandas
License:
AGBonnet commited on
Commit
4645073
·
1 Parent(s): e1f63cd

Update README.md

Browse files
Files changed (1) hide show
  1. README.md +32 -44
README.md CHANGED
@@ -42,41 +42,16 @@ You can scrape and clean all 16 guideline sources using our code in [epfLLM/medi
42
 
43
  ## Dataset Details
44
 
45
- ### Dataset Description
46
-
47
  <!-- Provide a longer summary of what this dataset is. -->
48
 
49
  - **Curated by:** [EPFL LLM Team](https://huggingface.co/epfl-llm)
50
  - **Funded by:** [More Information Needed]
51
  - **Language(s):** English only
52
  - **License:** [Common Crawl Foundation Terms of Use](https://commoncrawl.org/terms-of-use)
53
- - **Knowledge Cutoff**: August 2023
54
-
55
- ### Dataset Sources
56
-
57
- <!-- Provide the basic links for the dataset. -->
58
-
59
  - **Repository:** [epfLLM/meditron](https://github.com/epfLLM/meditron)
60
  - **Paper:** *[MediTron-70B: Scaling Medical Pretraining for Large Language Models]()*
 
61
 
62
- ## Uses
63
-
64
- <!-- Address questions around how the dataset is intended to be used. -->
65
-
66
-
67
- ### Direct Use
68
-
69
- <!-- This section describes suitable use cases for the dataset. -->
70
- The dataset is intended for use in tasks related to text generation, specifically in the context of clinical practice guidelines. It can be employed for training language models and other natural language processing applications within the healthcare domain.
71
-
72
- ### Out-of-Scope Use
73
-
74
- <!-- This section addresses misuse, malicious use, and uses that the dataset will not work well for. -->
75
-
76
- - **Redistribution: ** Please always check redistribution licenses before using the content as these may also evolve over time. To the best of our knowledge, we are following the redistribution licensing of each source and we invite users to inform us if that is not the case.
77
- - **Malicious use: ** We do not support any use of this corpus that may be harmful. Creating tools that provide clinical advice is commendable, but extremely dangerous if not done with the appropriate care. Such tools need to be validated for safety and utility by medical professionals in randomized controlled trials. i.e. Please don’t create cowboy health apps that fool vulnerable users into thinking they are receiving validated advice.
78
-
79
- [More Information Needed]
80
 
81
  ## Dataset Structure
82
 
@@ -95,7 +70,6 @@ Each row of the dataset represents one clinical practice guideline article, and
95
  | `clean_text`| Cleaned and formatted article text | All |
96
  | `overview` | Short summary of the article | NICE only |
97
 
98
-
99
  ## Dataset Creation
100
 
101
  ### Curation Rationale
@@ -103,21 +77,32 @@ Each row of the dataset represents one clinical practice guideline article, and
103
  <!-- Motivation for the creation of this dataset. -->
104
 
105
  The dataset was curated to provide a high-quality collection of clinical practice guidelines (CPGs) for the medical training of LLMs. Our Clinical Guidelines corpus comprises 46,469 articles from 16 globally recognized sources for clinician and patient-directed guidance across high and low-resource settings, multiple medical domains (internal medicine, pediatrics, oncology, infectious disease, etc.) and multiple geographical locations.
106
-
107
- Clinical practice guidelines are rigorously researched frameworks designed to guide healthcare practitioners and patients in making evidence-based decisions regarding diagnosis, treatment, and management.
108
- They are compiled through a systematic process of collaborative consensus between experts to establish recommendations from the latest evidence on best practices that would maximize benefit in light of practical concerns such as available resources and context. As a super-synthesis of meta-analyses, they sit atop the *evidence pyramid* and form the basis of actionable evidence-based practice.
109
- CPGs are produced at various geographic and organizational granularities, ranging from global to hospital-level initiatives directed by international professional medical associations to informal consortia, regional or national governmental bodies to individual NGOs and hospitals.
110
-
111
 
112
  ### Source Data
113
 
114
  <!-- This section describes the source data (e.g. news text and headlines, social media posts, translated sentences, ...). -->
115
 
116
- The dataset is sourced from 16 globally recognized medical entities, covering a wide range of healthcare contexts and audiences.
117
- For instance, the geographic scope ranges from global (WHO) to national (CDC, NICE) and regional (Ontario, Melbourne) to institutional (ICRC, Mayo Clinic). The corpus also represents health care concerns from high- (Ontario, Melbourne), low- (WHO), and volatile- (ICRC) resource settings.
 
 
 
118
  Guidelines also contains a range of technical and conversational vocabulary with target audiences of clinicians or patients (or both), and is sometimes highly specialized within a theme (cancer, pediatrics, infectious disease). The peer review processes also ranged from UN bodies (WHO), institutional review boards (ICRC), professional associations (AAFP) to publicly crowdsourced knowledge bases (WikiDoc).
119
  Article length varies widely from very short statements to 100+ page guides.
120
 
 
 
 
 
 
 
 
 
 
 
 
 
 
121
 
122
  #### Data Collection and Processing
123
 
@@ -129,23 +114,25 @@ This filtering procedure was performed differently for each source using a sampl
129
  Additionally, the text was standardized to a unified format with hierarchical section headers indicated by `'#'`, homogenous spacing `'\n\n'` separating paragraphs, and normalized lists formatted with `'- '` bullet points.
130
  Finally, all samples were deduplicated using title matching, and articles that were too short or not English were filtered out.
131
 
132
- #### Who are the source data producers?
133
 
134
- <!-- This section describes the people or systems who originally created the data. It should also include self-reported demographic or identity information for the source data creators if this information is available. -->
135
 
136
- We employed pragmatic selection criteria over medical sources, seeking CPGs that were:
137
 
138
- - (1) open-access
139
- - (2) systematically formatted with homogenous textual structure (i.e., in a format in which automated processes could be deployed without excessive risk of misaligning textual sequences)
140
- - (3) in the language predominantly represented by the pre-training corpus of Llama (i.e., English)
141
- - (4) covering a breadth of medical sub-domains, audiences (clinician, nurse, patient), and resource settings (high, low, and humanitarian response settings)
142
 
 
143
 
144
- #### Personal and Sensitive Information
145
 
146
- <!-- State whether the dataset contains data that might be considered personal, sensitive, or private (e.g., data that reveals addresses, uniquely identifiable names or aliases, racial or ethnic origins, sexual orientations, religious beliefs, political opinions, financial or health data, etc.). If efforts were made to anonymize the data, describe the anonymization process. -->
 
 
 
 
 
147
 
148
- As the articles are publicly accessible, no personal or sensitive information is included.
149
 
150
  ## Bias, Risks, and Limitations
151
 
@@ -167,6 +154,7 @@ We encourage users of this content to be mindful of its current limitations in t
167
  ## Acknowledgments
168
 
169
  The availability of open-access clinical practice guidelines (CPG) was critical to this work, and we thank all the societies listed above. A broader representation of geography, medical specialties, and contexts (especially low-resource settings) could be achieved through more standardized CPG formatting practices to ensure reliable textual extraction (e.g., releasing `.txt` or `.html` versions with structured content). We encourage the CPG community to continue to make these documents available (open-access with permissive licenses for incorporation into large language models) and easily usable.
 
170
  ## Authors
171
 
172
  - **Curation**: Mary-Anne Hartley
 
42
 
43
  ## Dataset Details
44
 
 
 
45
  <!-- Provide a longer summary of what this dataset is. -->
46
 
47
  - **Curated by:** [EPFL LLM Team](https://huggingface.co/epfl-llm)
48
  - **Funded by:** [More Information Needed]
49
  - **Language(s):** English only
50
  - **License:** [Common Crawl Foundation Terms of Use](https://commoncrawl.org/terms-of-use)
 
 
 
 
 
 
51
  - **Repository:** [epfLLM/meditron](https://github.com/epfLLM/meditron)
52
  - **Paper:** *[MediTron-70B: Scaling Medical Pretraining for Large Language Models]()*
53
+ - **Knowledge Cutoff**: August 2023
54
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
55
 
56
  ## Dataset Structure
57
 
 
70
  | `clean_text`| Cleaned and formatted article text | All |
71
  | `overview` | Short summary of the article | NICE only |
72
 
 
73
  ## Dataset Creation
74
 
75
  ### Curation Rationale
 
77
  <!-- Motivation for the creation of this dataset. -->
78
 
79
  The dataset was curated to provide a high-quality collection of clinical practice guidelines (CPGs) for the medical training of LLMs. Our Clinical Guidelines corpus comprises 46,469 articles from 16 globally recognized sources for clinician and patient-directed guidance across high and low-resource settings, multiple medical domains (internal medicine, pediatrics, oncology, infectious disease, etc.) and multiple geographical locations.
 
 
 
 
 
80
 
81
  ### Source Data
82
 
83
  <!-- This section describes the source data (e.g. news text and headlines, social media posts, translated sentences, ...). -->
84
 
85
+ Clinical practice guidelines are rigorously researched frameworks designed to guide healthcare practitioners and patients in making evidence-based decisions regarding diagnosis, treatment, and management.
86
+ They are compiled through a systematic process of collaborative consensus between experts to establish recommendations from the latest evidence on best practices that would maximize benefit in light of practical concerns such as available resources and context. As a super-synthesis of meta-analyses, they sit atop the *evidence pyramid* and form the basis of actionable evidence-based practice.
87
+
88
+ CPGs are produced at various geographic and organizational granularities, ranging from global to hospital-level initiatives directed by international professional medical associations to informal consortia, regional or national governmental bodies to individual NGOs and hospitals.
89
+ The geographic scope ranges from global (WHO) to national (CDC, NICE) and regional (Ontario, Melbourne) to institutional (ICRC, Mayo Clinic). The corpus also represents health care concerns from high- (Ontario, Melbourne), low- (WHO), and volatile- (ICRC) resource settings.
90
  Guidelines also contains a range of technical and conversational vocabulary with target audiences of clinicians or patients (or both), and is sometimes highly specialized within a theme (cancer, pediatrics, infectious disease). The peer review processes also ranged from UN bodies (WHO), institutional review boards (ICRC), professional associations (AAFP) to publicly crowdsourced knowledge bases (WikiDoc).
91
  Article length varies widely from very short statements to 100+ page guides.
92
 
93
+ #### Who are the source data producers?
94
+
95
+ <!-- This section describes the people or systems who originally created the data. It should also include self-reported demographic or identity information for the source data creators if this information is available. -->
96
+
97
+ The dataset is sourced from 16 globally recognized medical entities, covering a wide range of healthcare contexts and audiences.
98
+
99
+ We employed pragmatic selection criteria over medical sources, seeking CPGs that were:
100
+
101
+ - (1) open-access
102
+ - (2) systematically formatted with homogenous textual structure (i.e., in a format in which automated processes could be deployed without excessive risk of misaligning textual sequences)
103
+ - (3) in the language predominantly represented by the pre-training corpus of Llama (i.e., English)
104
+ - (4) covering a breadth of medical sub-domains, audiences (clinician, nurse, patient), and resource settings (high, low, and humanitarian response settings)
105
+
106
 
107
  #### Data Collection and Processing
108
 
 
114
  Additionally, the text was standardized to a unified format with hierarchical section headers indicated by `'#'`, homogenous spacing `'\n\n'` separating paragraphs, and normalized lists formatted with `'- '` bullet points.
115
  Finally, all samples were deduplicated using title matching, and articles that were too short or not English were filtered out.
116
 
117
+ #### Personal and Sensitive Information
118
 
119
+ <!-- State whether the dataset contains data that might be considered personal, sensitive, or private (e.g., data that reveals addresses, uniquely identifiable names or aliases, racial or ethnic origins, sexual orientations, religious beliefs, political opinions, financial or health data, etc.). If efforts were made to anonymize the data, describe the anonymization process. -->
120
 
121
+ As the articles are publicly accessible, no personal or sensitive information is included.
122
 
123
+ ## Uses
 
 
 
124
 
125
+ <!-- Address questions around how the dataset is intended to be used. -->
126
 
127
+ The dataset is intended for use in tasks related to text generation, specifically in the context of clinical practice guidelines. It can be employed for training language models and other natural language processing applications within the healthcare domain.
128
 
129
+ ### Out-of-Scope Use
130
+
131
+ <!-- This section addresses misuse, malicious use, and uses that the dataset will not work well for. -->
132
+
133
+ - **Redistribution**: Please always check redistribution licenses before using the content as these may also evolve over time. To the best of our knowledge, we are following the redistribution licensing of each source and we invite users to inform us if that is not the case.
134
+ - **Malicious use**: We do not support any use of this corpus that may be harmful. Creating tools that provide clinical advice is commendable, but extremely dangerous if not done with the appropriate care. Such tools need to be validated for safety and utility by medical professionals in randomized controlled trials. i.e. please do not create cowboy health apps that fool vulnerable users into thinking they are receiving validated advice.
135
 
 
136
 
137
  ## Bias, Risks, and Limitations
138
 
 
154
  ## Acknowledgments
155
 
156
  The availability of open-access clinical practice guidelines (CPG) was critical to this work, and we thank all the societies listed above. A broader representation of geography, medical specialties, and contexts (especially low-resource settings) could be achieved through more standardized CPG formatting practices to ensure reliable textual extraction (e.g., releasing `.txt` or `.html` versions with structured content). We encourage the CPG community to continue to make these documents available (open-access with permissive licenses for incorporation into large language models) and easily usable.
157
+
158
  ## Authors
159
 
160
  - **Curation**: Mary-Anne Hartley